title: [Is bone biopsy necessary for the diagnosis of metabolic bone diseases? Non- invasive assessment of bone turn over markers could define the cause of metabolic bone diseases].
abstract: Recent advances of the measurement of bone turn over markers contribute to non-invasive assessment of bone-metabolic disorders. We can detect the cause of the metabolic disorders with bone turn over markers and hormonal profiles more easily than before. Today, we can diagnose and treat metabolic bone diseases without invasive procedure such as bone biopsy.
authors: Department of Internal Medicine, Fujita Health University, Japan.
authors: Atsushi
authors: A
authors: Suzuki
mesh_terms: D000135:Acid Phosphatase / Q000032:analysis; D000469:Alkaline Phosphatase / Q000032:analysis; D001120:Arginine / Q000031:analogs & derivatives / Q000032:analysis; D015415:Biomarkers / Q000032:analysis; D001706:Biopsy; D001851:Bone Diseases, Metabolic / Q000175:diagnosis* / Q000209:etiology* / Q000628:therapy; D001842:Bone and Bones / Q000473:pathology*; D024042:Collagen Type I / Q000032:analysis; D003937:Diagnosis, Differential; D006710:Homocysteine / Q000032:analysis; D006801:Humans; D007527:Isoenzymes / Q000032:analysis; D008239:Lysine / Q000031:analogs & derivatives / Q000032:analysis; D010024:Osteoporosis / Q000175:diagnosis / Q000188:drug therapy; D010446:Peptide Fragments / Q000032:analysis; D010455:Peptides / Q000032:analysis; D011347:Procollagen / Q000032:analysis; D000071681:Tartrate-Resistant Acid Phosphatase
chemical_list: D015415:Biomarkers; D024042:Collagen Type I; D007527:Isoenzymes; D010446:Peptide Fragments; D010455:Peptides; D011347:Procollagen; C052929:collagen type I trimeric cross-linked peptide; C093212:procollagen type II carboxy-terminal peptide; D006710:Homocysteine; D001120:Arginine; C062187:pentosidine; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D000071681:Tartrate-Resistant Acid Phosphatase; D008239:Lysine